{"id":134262,"date":"2024-09-24T10:59:33","date_gmt":"2024-09-24T05:29:33","guid":{"rendered":"https:\/\/tradebrains.in\/features\/?p=134262"},"modified":"2024-09-24T11:02:17","modified_gmt":"2024-09-24T05:32:17","slug":"pharma-stock-jumps-12-after-it-receives-nod-to-import-drugs-for-cancer-and-tumors","status":"publish","type":"post","link":"https:\/\/tradebrains.in\/features\/pharma-stock-jumps-12-after-it-receives-nod-to-import-drugs-for-cancer-and-tumors\/","title":{"rendered":"Pharma stock jumps 12% after it receives nod to import drugs for cancer and tumors"},"content":{"rendered":"<div class=\"trade-content_2\" style=\"margin-left: auto;margin-right: auto;text-align: center;\" id=\"trade-4091543818\"><p><a href=\"https:\/\/tradebrains.in\/get\/telegram\/\"><img decoding=\"async\" class=\"alignnone wp-image-101992\" src=\"https:\/\/tradebrains.in\/features\/wp-content\/uploads\/2023\/01\/telegram-channel-300x119.png\" alt=\"\" width=\"148\" height=\"59\" \/><\/a> <a href=\"https:\/\/news.google.com\/publications\/CAAqBwgKMN3Epgswxc--Aw?hl=en-IN&amp;gl=IN&amp;ceid=IN%3Aen\"><img decoding=\"async\" class=\"alignnone wp-image-123430\" src=\"https:\/\/tradebrains.in\/features\/wp-content\/uploads\/2024\/05\/follow-on-google-news-300x82.png\" alt=\"follow-on-google-news\" width=\"222\" height=\"61\" srcset=\"https:\/\/tradebrains.in\/features\/wp-content\/uploads\/2024\/05\/follow-on-google-news-300x82.png 300w, https:\/\/tradebrains.in\/features\/wp-content\/uploads\/2024\/05\/follow-on-google-news-150x41.png 150w, https:\/\/tradebrains.in\/features\/wp-content\/uploads\/2024\/05\/follow-on-google-news.png 468w\" sizes=\"(max-width: 222px) 100vw, 222px\" \/><\/a><\/p>\n<\/div><p>Pharma stock is engaged in manufacturing, distributing, and marketing pharmaceutical products catering to various medical areas jumped 12 percent in the day\u2019s trade upon receiving approval to import for sale and distribution of drug used to treat cancer and tumors.&nbsp;<\/p><div class=\"trade-content_7\" style=\"margin-left: auto;margin-right: auto;text-align: center;\" id=\"trade-2986056659\"><!-- Composite Start --> \r\n <div id=\"M923760ScriptRootC1549812\"> \r\n <\/div> \r\n <script src=\"https:\/\/jsc.mgid.com\/t\/r\/tradebrains.in.1549812.js\" async> \r\n <\/script> \r\n <!-- Composite End --><\/div><h2 class=\"wp-block-heading has-medium-font-size\"><strong>Price action&nbsp;<\/strong><\/h2><p>With a market capitalization of Rs. 18,728 Crores, the shares of <strong><a href=\"https:\/\/portal.tradebrains.in\/stock\/ASTRAZEN\/standalone\" target=\"_blank\" rel=\"noreferrer noopener\">Astrazeneca Pharma India Limited<\/a><\/strong> were trading at Rs. 7,490 per equity share, up 11 percent from its previous day\u2019s close price of Rs. 6,746.45.\u00a0<\/p><h2 class=\"wp-block-heading has-medium-font-size\"><strong>What Happened&nbsp;<\/strong><\/h2><p>AstraZeneca Pharma India Limited has received permission to import for sale and distribution of Durvalumab 120 mg\/2.4 mL and 500 mg\/10 mL solution for infusion (Imfinzi) from the Central Drugs Standard Control Organisation, Directorate General of Health Services, Government of India.&nbsp;<\/p><p>Durvalumab (IMFINZI) in combination with chemotherapy as neoadjuvant treatment, followed by IMFINZI as monotherapy after surgery, is indicated for the treatment of patients with resectable (tumours 4 cm and\/or node positive) NSCLC and no known epidermal growth factor receptor (EGFR) mutations or anaplastic lymphoma kinase (ALK) rearrangements&nbsp;<\/p><div class=\"trade-content_5\" id=\"trade-3624642890\"><script async src=\"https:\/\/pagead2.googlesyndication.com\/pagead\/js\/adsbygoogle.js?client=ca-pub-4023722985638610\"\r\n     crossorigin=\"anonymous\"><\/script>\r\n<!-- in_content_2_news -->\r\n<ins class=\"adsbygoogle\"\r\n     style=\"display:block\"\r\n     data-ad-client=\"ca-pub-4023722985638610\"\r\n     data-ad-slot=\"7925020301\"\r\n     data-ad-format=\"auto\"\r\n     data-full-width-responsive=\"true\"><\/ins>\r\n<script>\r\n     (adsbygoogle = window.adsbygoogle || []).push({});\r\n<\/script><\/div><blockquote class=\"wp-block-quote is-layout-flow wp-block-quote-is-layout-flow\"><p><strong>Also Read: <a href=\"https:\/\/tradebrains.in\/features\/ambani-group-stock-jumps-3-after-receiving-solar-epc-orders-worth-512-cr\/\" target=\"_blank\" rel=\"noreferrer noopener\">Ambani group stock jumps 3% after receiving solar EPC orders worth \u20b9 512 Cr<\/a><\/strong><\/p><\/blockquote><p>Durvalumab belonging to a class of drugs known as immune checkpoint inhibitors, is a monoclonal antibody used in cancer immunotherapy. Durvalumab targets and blocks the PD-L1 (programmed death-ligand 1) protein, allowing the immune system to detect and attack cancer cells more effectively.&nbsp;<\/p><h2 class=\"wp-block-heading has-medium-font-size\"><strong>About the Company&nbsp;<\/strong><\/h2><p>AstraZeneca Pharma India Limited is engaged in manufacturing, distributing, and marketing pharmaceutical products catering to various medical areas, including Cardiovascular, Renal, and Metabolic (CVRM) Diseases, Oncology, Respiratory, and Immunology.&nbsp;<\/p><p>It offers pharmaceutical medicines under notable brands such as Brilinta, Forxiga, Crestor, Tagrisso, Calquence, Zoladex, Symbicort, and many more&nbsp;<\/p><h2 class=\"wp-block-heading has-medium-font-size\"><strong>Financials &amp; Ratios&nbsp;<\/strong><\/h2><p>Its revenue from operations grew by 31.15 percent from Rs. 295 Crores in Q1FY24 to Rs. 388 Crores in Q1FY25, accompanied by profits of Rs. 54 Crores to a loss of Rs. 12 Crores.<\/p><p>In terms of return ratios, it has reported a return on equity (ROE) of 22.9 percent and a return on capital employed (ROCE) of 31.1 percent. In terms of liquidity, it has reported a debt-to-equity ratio of 0.01.&nbsp;<\/p><blockquote class=\"wp-block-quote is-layout-flow wp-block-quote-is-layout-flow\"><p><strong>Also Read: <a href=\"https:\/\/tradebrains.in\/features\/alcohol-stock-with-strong-revenue-growth-guidance-for-fy25-to-add-to-your-watchlist\/\" target=\"_blank\" rel=\"noreferrer noopener\">Alcohol stock with strong revenue growth guidance for FY25 to add to your watchlis<\/a>t<\/strong><\/p><\/blockquote><blockquote class=\"wp-block-quote is-layout-flow wp-block-quote-is-layout-flow\"><p><strong>Written by: Bharath K.S<\/strong><\/p><\/blockquote><h4 class=\"wp-block-heading has-medium-font-size\" id=\"h-disclaimer\"><strong>Disclaimer<\/strong><\/h4><div class=\"wp-block-image\"><figure class=\"aligncenter size-medium\"><img decoding=\"async\" width=\"300\" height=\"300\" src=\"https:\/\/tradebrains.in\/features\/wp-content\/uploads\/2022\/02\/warning-disclaimer-300x300.png\" alt=\"\" class=\"wp-image-26306\"\/><\/figure><\/div><p><strong>The views and investment tips expressed by investment experts\/broking houses\/rating agencies on <a href=\"http:\/\/tradebrains.in\/\">tradebrains.in<\/a> are their own, and not that of the website or its management. Investing in equities poses a risk of financial losses. Investors must therefore exercise due caution while investing or trading in stocks. Dailyraven Technologies or the author are not liable for any losses caused as a result of the decision based on this article. Please consult your investment advisor before investing<\/strong>.<\/p><div class=\"trade-content-10\" id=\"trade-546067988\"><script async src=\"https:\/\/pagead2.googlesyndication.com\/pagead\/js\/adsbygoogle.js?client=ca-pub-4023722985638610\"\r\n     crossorigin=\"anonymous\"><\/script>\r\n<!-- in_content_3_news -->\r\n<ins class=\"adsbygoogle\"\r\n     style=\"display:block\"\r\n     data-ad-client=\"ca-pub-4023722985638610\"\r\n     data-ad-slot=\"2969612066\"\r\n     data-ad-format=\"auto\"\r\n     data-full-width-responsive=\"true\"><\/ins>\r\n<script>\r\n     (adsbygoogle = window.adsbygoogle || []).push({});\r\n<\/script><\/div><div class=\"trade-after-content\" id=\"trade-2245556551\"><div id=\"taboola-below-article-thumbnails\"><\/div>\r\n<script type=\"text\/javascript\">\r\n  window._taboola = window._taboola || [];\r\n  _taboola.push({\r\n    mode: 'alternating-thumbnails-a',\r\n    container: 'taboola-below-article-thumbnails',\r\n    placement: 'Below Article Thumbnails',\r\n    target_type: 'mix'\r\n  });\r\n<\/script>\r\n<script type=\"text\/javascript\">\r\n  window._taboola = window._taboola || [];\r\n  _taboola.push({flush: true});\r\n<\/script><\/div>","protected":false},"excerpt":{"rendered":"<p>Pharma stock is engaged in manufacturing, distributing, and marketing pharmaceutical products catering to various medical areas jumped 12 percent in the day\u2019s trade upon receiving approval to import for sale and distribution of drug used to treat cancer and tumors.&nbsp; Price action&nbsp; With a market capitalization of Rs. 18,728 Crores, the shares of Astrazeneca Pharma [&hellip;]<\/p>\n","protected":false},"author":5,"featured_media":111747,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"_et_pb_use_builder":"","_et_pb_old_content":"","_et_gb_content_width":"","footnotes":""},"categories":[31,1789],"tags":[18722,17415,22817,17414,17413,6616,948,936,3157],"class_list":["post-134262","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-news","category-trending-news","tag-astrazeneca-pharma","tag-astrazeneca-pharma-cancer-drug","tag-astrazeneca-pharma-india","tag-astrazeneca-pharma-latest-news","tag-astrazeneca-pharma-share-price","tag-pharma-stock","tag-stock-market","tag-stock-market-news","tag-stock-to-watch"],"yoast_head":"<!-- This site is optimized with the Yoast SEO Premium plugin v20.5 (Yoast SEO v25.0) - https:\/\/yoast.com\/wordpress\/plugins\/seo\/ -->\n<title>Pharma stock jumps 12% after it receives nod to import drugs for cancer and tumors - Trade Brains Features<\/title>\n<meta name=\"description\" content=\"Pharma stock is engaged in manufacturing, distributing, and marketing pharmaceutical products catering to various medical areas jumped 12 percent in the day\u2019s trade upon receiving approval to import for sale and distribution of drug used to treat cancer and tumors.\u00a0\" \/>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/tradebrains.in\/features\/pharma-stock-jumps-12-after-it-receives-nod-to-import-drugs-for-cancer-and-tumors\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Pharma stock jumps 12% after it receives nod to import drugs for cancer and tumors\" \/>\n<meta property=\"og:description\" content=\"Pharma stock is engaged in manufacturing, distributing, and marketing pharmaceutical products catering to various medical areas jumped 12 percent in the day\u2019s trade upon receiving approval to import for sale and distribution of drug used to treat cancer and tumors.\u00a0\" \/>\n<meta property=\"og:url\" content=\"https:\/\/tradebrains.in\/features\/pharma-stock-jumps-12-after-it-receives-nod-to-import-drugs-for-cancer-and-tumors\/\" \/>\n<meta property=\"og:site_name\" content=\"Trade Brains Features\" \/>\n<meta property=\"article:publisher\" content=\"https:\/\/www.facebook.com\/TradeBrainsOfficial\/\" \/>\n<meta property=\"article:published_time\" content=\"2024-09-24T05:29:33+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2024-09-24T05:32:17+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/tradebrains.in\/features\/wp-content\/uploads\/2023\/10\/pharma03.jpg\" \/>\n\t<meta property=\"og:image:width\" content=\"1280\" \/>\n\t<meta property=\"og:image:height\" content=\"854\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/jpeg\" \/>\n<meta name=\"author\" content=\"Trade Brains\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:creator\" content=\"@TradeBrainsGrp\" \/>\n<meta name=\"twitter:site\" content=\"@TradeBrainsGrp\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Trade Brains\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"3 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"WebPage\",\"@id\":\"https:\/\/tradebrains.in\/features\/pharma-stock-jumps-12-after-it-receives-nod-to-import-drugs-for-cancer-and-tumors\/\",\"url\":\"https:\/\/tradebrains.in\/features\/pharma-stock-jumps-12-after-it-receives-nod-to-import-drugs-for-cancer-and-tumors\/\",\"name\":\"Pharma stock jumps 12% after it receives nod to import drugs for cancer and tumors - Trade Brains Features\",\"isPartOf\":{\"@id\":\"https:\/\/tradebrains.in\/features\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\/\/tradebrains.in\/features\/pharma-stock-jumps-12-after-it-receives-nod-to-import-drugs-for-cancer-and-tumors\/#primaryimage\"},\"image\":{\"@id\":\"https:\/\/tradebrains.in\/features\/pharma-stock-jumps-12-after-it-receives-nod-to-import-drugs-for-cancer-and-tumors\/#primaryimage\"},\"thumbnailUrl\":\"https:\/\/tradebrains.in\/features\/wp-content\/uploads\/2023\/10\/pharma03.jpg\",\"datePublished\":\"2024-09-24T05:29:33+00:00\",\"dateModified\":\"2024-09-24T05:32:17+00:00\",\"author\":{\"@id\":\"https:\/\/tradebrains.in\/features\/#\/schema\/person\/640937d840c7695c8f8995dd15ae0666\"},\"description\":\"Pharma stock is engaged in manufacturing, distributing, and marketing pharmaceutical products catering to various medical areas jumped 12 percent in the day\u2019s trade upon receiving approval to import for sale and distribution of drug used to treat cancer and tumors.\u00a0\",\"breadcrumb\":{\"@id\":\"https:\/\/tradebrains.in\/features\/pharma-stock-jumps-12-after-it-receives-nod-to-import-drugs-for-cancer-and-tumors\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/tradebrains.in\/features\/pharma-stock-jumps-12-after-it-receives-nod-to-import-drugs-for-cancer-and-tumors\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/tradebrains.in\/features\/pharma-stock-jumps-12-after-it-receives-nod-to-import-drugs-for-cancer-and-tumors\/#primaryimage\",\"url\":\"https:\/\/tradebrains.in\/features\/wp-content\/uploads\/2023\/10\/pharma03.jpg\",\"contentUrl\":\"https:\/\/tradebrains.in\/features\/wp-content\/uploads\/2023\/10\/pharma03.jpg\",\"width\":1280,\"height\":854},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/tradebrains.in\/features\/pharma-stock-jumps-12-after-it-receives-nod-to-import-drugs-for-cancer-and-tumors\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\/\/tradebrains.in\/features\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Pharma stock jumps 12% after it receives nod to import drugs for cancer and tumors\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/tradebrains.in\/features\/#website\",\"url\":\"https:\/\/tradebrains.in\/features\/\",\"name\":\"Trade Brains\",\"description\":\"Stock Market NSE\/BSE Latest News\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/tradebrains.in\/features\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Person\",\"@id\":\"https:\/\/tradebrains.in\/features\/#\/schema\/person\/640937d840c7695c8f8995dd15ae0666\",\"name\":\"Trade Brains\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/tradebrains.in\/features\/#\/schema\/person\/image\/\",\"url\":\"https:\/\/secure.gravatar.com\/avatar\/bd7d6331c5ab74181158fb2f0f0d9eada16909507ed513a20867478cf3bbdd43?s=96&d=mm&r=g\",\"contentUrl\":\"https:\/\/secure.gravatar.com\/avatar\/bd7d6331c5ab74181158fb2f0f0d9eada16909507ed513a20867478cf3bbdd43?s=96&d=mm&r=g\",\"caption\":\"Trade Brains\"},\"sameAs\":[\"http:\/\/tradebrains.in\/\"],\"url\":\"https:\/\/tradebrains.in\/features\/author\/trade-brains\/\"}]}<\/script>\n<!-- \/ Yoast SEO Premium plugin. -->","yoast_head_json":{"title":"Pharma stock jumps 12% after it receives nod to import drugs for cancer and tumors - Trade Brains Features","description":"Pharma stock is engaged in manufacturing, distributing, and marketing pharmaceutical products catering to various medical areas jumped 12 percent in the day\u2019s trade upon receiving approval to import for sale and distribution of drug used to treat cancer and tumors.\u00a0","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/tradebrains.in\/features\/pharma-stock-jumps-12-after-it-receives-nod-to-import-drugs-for-cancer-and-tumors\/","og_locale":"en_US","og_type":"article","og_title":"Pharma stock jumps 12% after it receives nod to import drugs for cancer and tumors","og_description":"Pharma stock is engaged in manufacturing, distributing, and marketing pharmaceutical products catering to various medical areas jumped 12 percent in the day\u2019s trade upon receiving approval to import for sale and distribution of drug used to treat cancer and tumors.\u00a0","og_url":"https:\/\/tradebrains.in\/features\/pharma-stock-jumps-12-after-it-receives-nod-to-import-drugs-for-cancer-and-tumors\/","og_site_name":"Trade Brains Features","article_publisher":"https:\/\/www.facebook.com\/TradeBrainsOfficial\/","article_published_time":"2024-09-24T05:29:33+00:00","article_modified_time":"2024-09-24T05:32:17+00:00","og_image":[{"width":1280,"height":854,"url":"https:\/\/tradebrains.in\/features\/wp-content\/uploads\/2023\/10\/pharma03.jpg","type":"image\/jpeg"}],"author":"Trade Brains","twitter_card":"summary_large_image","twitter_creator":"@TradeBrainsGrp","twitter_site":"@TradeBrainsGrp","twitter_misc":{"Written by":"Trade Brains","Est. reading time":"3 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"WebPage","@id":"https:\/\/tradebrains.in\/features\/pharma-stock-jumps-12-after-it-receives-nod-to-import-drugs-for-cancer-and-tumors\/","url":"https:\/\/tradebrains.in\/features\/pharma-stock-jumps-12-after-it-receives-nod-to-import-drugs-for-cancer-and-tumors\/","name":"Pharma stock jumps 12% after it receives nod to import drugs for cancer and tumors - Trade Brains Features","isPartOf":{"@id":"https:\/\/tradebrains.in\/features\/#website"},"primaryImageOfPage":{"@id":"https:\/\/tradebrains.in\/features\/pharma-stock-jumps-12-after-it-receives-nod-to-import-drugs-for-cancer-and-tumors\/#primaryimage"},"image":{"@id":"https:\/\/tradebrains.in\/features\/pharma-stock-jumps-12-after-it-receives-nod-to-import-drugs-for-cancer-and-tumors\/#primaryimage"},"thumbnailUrl":"https:\/\/tradebrains.in\/features\/wp-content\/uploads\/2023\/10\/pharma03.jpg","datePublished":"2024-09-24T05:29:33+00:00","dateModified":"2024-09-24T05:32:17+00:00","author":{"@id":"https:\/\/tradebrains.in\/features\/#\/schema\/person\/640937d840c7695c8f8995dd15ae0666"},"description":"Pharma stock is engaged in manufacturing, distributing, and marketing pharmaceutical products catering to various medical areas jumped 12 percent in the day\u2019s trade upon receiving approval to import for sale and distribution of drug used to treat cancer and tumors.\u00a0","breadcrumb":{"@id":"https:\/\/tradebrains.in\/features\/pharma-stock-jumps-12-after-it-receives-nod-to-import-drugs-for-cancer-and-tumors\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/tradebrains.in\/features\/pharma-stock-jumps-12-after-it-receives-nod-to-import-drugs-for-cancer-and-tumors\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/tradebrains.in\/features\/pharma-stock-jumps-12-after-it-receives-nod-to-import-drugs-for-cancer-and-tumors\/#primaryimage","url":"https:\/\/tradebrains.in\/features\/wp-content\/uploads\/2023\/10\/pharma03.jpg","contentUrl":"https:\/\/tradebrains.in\/features\/wp-content\/uploads\/2023\/10\/pharma03.jpg","width":1280,"height":854},{"@type":"BreadcrumbList","@id":"https:\/\/tradebrains.in\/features\/pharma-stock-jumps-12-after-it-receives-nod-to-import-drugs-for-cancer-and-tumors\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/tradebrains.in\/features\/"},{"@type":"ListItem","position":2,"name":"Pharma stock jumps 12% after it receives nod to import drugs for cancer and tumors"}]},{"@type":"WebSite","@id":"https:\/\/tradebrains.in\/features\/#website","url":"https:\/\/tradebrains.in\/features\/","name":"Trade Brains","description":"Stock Market NSE\/BSE Latest News","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/tradebrains.in\/features\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Person","@id":"https:\/\/tradebrains.in\/features\/#\/schema\/person\/640937d840c7695c8f8995dd15ae0666","name":"Trade Brains","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/tradebrains.in\/features\/#\/schema\/person\/image\/","url":"https:\/\/secure.gravatar.com\/avatar\/bd7d6331c5ab74181158fb2f0f0d9eada16909507ed513a20867478cf3bbdd43?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/bd7d6331c5ab74181158fb2f0f0d9eada16909507ed513a20867478cf3bbdd43?s=96&d=mm&r=g","caption":"Trade Brains"},"sameAs":["http:\/\/tradebrains.in\/"],"url":"https:\/\/tradebrains.in\/features\/author\/trade-brains\/"}]}},"_links":{"self":[{"href":"https:\/\/tradebrains.in\/features\/wp-json\/wp\/v2\/posts\/134262","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/tradebrains.in\/features\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/tradebrains.in\/features\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/tradebrains.in\/features\/wp-json\/wp\/v2\/users\/5"}],"replies":[{"embeddable":true,"href":"https:\/\/tradebrains.in\/features\/wp-json\/wp\/v2\/comments?post=134262"}],"version-history":[{"count":2,"href":"https:\/\/tradebrains.in\/features\/wp-json\/wp\/v2\/posts\/134262\/revisions"}],"predecessor-version":[{"id":134265,"href":"https:\/\/tradebrains.in\/features\/wp-json\/wp\/v2\/posts\/134262\/revisions\/134265"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/tradebrains.in\/features\/wp-json\/wp\/v2\/media\/111747"}],"wp:attachment":[{"href":"https:\/\/tradebrains.in\/features\/wp-json\/wp\/v2\/media?parent=134262"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/tradebrains.in\/features\/wp-json\/wp\/v2\/categories?post=134262"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/tradebrains.in\/features\/wp-json\/wp\/v2\/tags?post=134262"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}